Skip to main content
. 2022 Jun 21;14(7):1314. doi: 10.3390/pharmaceutics14071314

Figure 8.

Figure 8

In vivo therapeutic efficacy of the combination of IMP301 and ultrasound in MDA-MB-231 mice after three rounds of treatment. (a) Tumor growth in MDA-MB-231 tumor-bearing mice intravenously administrated with saline (control; black line), IMP301 (IMP301 US-; red line), and IMP301 with FUS irradiation (IMP301 US+; blue line). (b) Body weight change of mice in each group; (n = 3).